REMIMAZOLAM for Sedative therapy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 17 adverse event reports in the FDA FAERS database where REMIMAZOLAM was used for Sedative therapy.
Most Reported Side Effects for REMIMAZOLAM
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Anaphylactic shock | 21 | 15.3% | 0 | 4 |
| Anaphylactic reaction | 11 | 8.0% | 2 | 3 |
| Vascular access site occlusion | 11 | 8.0% | 0 | 0 |
| Cardiac arrest | 10 | 7.3% | 0 | 5 |
| Hypotension | 10 | 7.3% | 0 | 1 |
| Oxygen saturation decreased | 9 | 6.6% | 0 | 1 |
| Blood pressure decreased | 8 | 5.8% | 0 | 1 |
| Off label use | 8 | 5.8% | 0 | 3 |
| Bronchospasm | 6 | 4.4% | 2 | 3 |
| Circulatory collapse | 6 | 4.4% | 0 | 1 |
| Drug ineffective | 6 | 4.4% | 0 | 1 |
| Respiratory depression | 6 | 4.4% | 0 | 4 |
| Tachycardia | 6 | 4.4% | 0 | 0 |
| Electrocardiogram qt prolonged | 5 | 3.7% | 0 | 3 |
| Erythema | 5 | 3.7% | 0 | 0 |
Other Indications for REMIMAZOLAM
General anaesthesia (40)
Induction of anaesthesia (25)
Anaesthesia (17)
Product used for unknown indication (16)
Other Drugs Used for Sedative therapy
PROPOFOL (904)
MIDAZOLAM (630)
DEXMEDETOMIDINE (604)
FENTANYL (376)
KETAMINE (197)
DIAZEPAM (101)
MIDAZOLAM\MIDAZOLAM (91)
MORPHINE (89)
LORAZEPAM (87)
SUFENTANIL (74)